Dianthus Therapeutics, Inc. /DE/ (DNTH)
Nasdaq: DNTH · CIK 0001690585 · United States
Every official Dianthus Therapeutics, Inc. /DE/ filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open DNTH filings
Dianthus Therapeutics, Inc. /DE/ documents
- Dianthus Therapeutics, Inc. /DE/ 10-K 2026DNTH 10-K 2026: annual report for fiscal 2026
- Dianthus Therapeutics, Inc. /DE/ 10-K 2025DNTH 10-K 2025: annual report for fiscal 2025
- Dianthus Therapeutics, Inc. /DE/ 10-K 2024DNTH 10-K 2024: annual report for fiscal 2024
- Dianthus Therapeutics, Inc. /DE/ 10-K 2023DNTH 10-K 2023: annual report for fiscal 2023
- Dianthus Therapeutics, Inc. /DE/ 10-K 2022DNTH 10-K 2022: annual report for fiscal 2022
- Dianthus Therapeutics, Inc. /DE/ 10-Q 2026DNTH 10-Q 2026: quarterly report for fiscal 2026
- Dianthus Therapeutics, Inc. /DE/ 10-Q 2025DNTH 10-Q 2025: quarterly report for fiscal 2025
- Dianthus Therapeutics, Inc. /DE/ 10-Q 2024DNTH 10-Q 2024: quarterly report for fiscal 2024
- Dianthus Therapeutics, Inc. /DE/ 10-Q 2023DNTH 10-Q 2023: quarterly report for fiscal 2023
- Dianthus Therapeutics, Inc. /DE/ 10-Q 2022DNTH 10-Q 2022: quarterly report for fiscal 2022
- Dianthus Therapeutics, Inc. /DE/ 8-K 2026DNTH 8-K 2026: current report for fiscal 2026
- Dianthus Therapeutics, Inc. /DE/ 8-K 2025DNTH 8-K 2025: current report for fiscal 2025
- Dianthus Therapeutics, Inc. /DE/ 8-K 2024DNTH 8-K 2024: current report for fiscal 2024
- Dianthus Therapeutics, Inc. /DE/ 8-K 2023DNTH 8-K 2023: current report for fiscal 2023
- Dianthus Therapeutics, Inc. /DE/ 8-K 2022DNTH 8-K 2022: current report for fiscal 2022
- Dianthus Therapeutics, Inc. /DE/ DEF 14A 2026DNTH DEF 14A 2026: proxy statement for fiscal 2026
- Dianthus Therapeutics, Inc. /DE/ DEF 14A 2025DNTH DEF 14A 2025: proxy statement for fiscal 2025
- Dianthus Therapeutics, Inc. /DE/ DEF 14A 2024DNTH DEF 14A 2024: proxy statement for fiscal 2024
- Dianthus Therapeutics, Inc. /DE/ DEF 14A 2023DNTH DEF 14A 2023: proxy statement for fiscal 2023
- Dianthus Therapeutics, Inc. /DE/ DEF 14A 2022DNTH DEF 14A 2022: proxy statement for fiscal 2022
- Dianthus Therapeutics, Inc. /DE/ Form 4 2026DNTH Form 4 2026: insider trading filing for fiscal 2026
- Dianthus Therapeutics, Inc. /DE/ Form 4 2025DNTH Form 4 2025: insider trading filing for fiscal 2025
- Dianthus Therapeutics, Inc. /DE/ Form 4 2024DNTH Form 4 2024: insider trading filing for fiscal 2024
- Dianthus Therapeutics, Inc. /DE/ Form 4 2023DNTH Form 4 2023: insider trading filing for fiscal 2023
- Dianthus Therapeutics, Inc. /DE/ Form 4 2022DNTH Form 4 2022: insider trading filing for fiscal 2022
- Dianthus Therapeutics, Inc. /DE/ S-1 2026DNTH S-1 2026: registration statement for fiscal 2026
- Dianthus Therapeutics, Inc. /DE/ S-1 2025DNTH S-1 2025: registration statement for fiscal 2025
- Dianthus Therapeutics, Inc. /DE/ S-1 2024DNTH S-1 2024: registration statement for fiscal 2024
- Dianthus Therapeutics, Inc. /DE/ S-1 2023DNTH S-1 2023: registration statement for fiscal 2023
- Dianthus Therapeutics, Inc. /DE/ S-1 2022DNTH S-1 2022: registration statement for fiscal 2022
- Dianthus Therapeutics, Inc. /DE/ 13F 2026DNTH 13F 2026: institutional holdings for fiscal 2026
- Dianthus Therapeutics, Inc. /DE/ 13F 2025DNTH 13F 2025: institutional holdings for fiscal 2025
- Dianthus Therapeutics, Inc. /DE/ 13F 2024DNTH 13F 2024: institutional holdings for fiscal 2024
- Dianthus Therapeutics, Inc. /DE/ 13F 2023DNTH 13F 2023: institutional holdings for fiscal 2023
- Dianthus Therapeutics, Inc. /DE/ 13F 2022DNTH 13F 2022: institutional holdings for fiscal 2022
More companies